ENDOTAK RELIANCE
Report
- Report Number
- 2124215-2024-58255
- Event Type
- Injury
- Date Received
- September 18, 2024
- Date of Event
- August 20, 2024
- Report Date
- April 15, 2026
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- LWS
- UDI-DI
- 00802526531125
- PMA / PMN Number
- P910073/S039
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AR, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
CORRECTION TO FIELD F10. DEVICE CODES. THIS SUPPLEMENTAL CORRECTION REPORT WAS CREATED TO CAPTURE UPDATES ON D2A: COMMON DEVICE NAME.
CORRECTION TO FIELD F10. DEVICE CODES.
IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD PACE/SENSE PART WAS SURGICALLY CAPPED. FURTHERMORE, THE OTHER RV LEAD WAS USED FOR PACING AND SENSING. THIS LEAD REMAINS IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD PACE/SENSE PART WAS SURGICALLY CAPPED. FURTHERMORE, THE OTHER RV LEAD WAS USED FOR PACING AND SENSING. THIS LEAD REMAINS IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. ADDITIONAL INFORMATION RECEIVED FROM THE FIELD INDICATING THAT THIS LEAD PACE/SENSE PART WAS SURGICALLY ABANDONED AS THIS IS A STANDARD OPERATING PROCEDURE FOR THIS ELECTROPHYSIOLOGY AT UPGRADES.
IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD PACE/SENSE PART WAS SURGICALLY CAPPED. FURTHERMORE, THE OTHER RV LEAD WAS USED FOR PACING AND SENSING. THIS LEAD REMAINS IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. ADDITIONAL INFORMATION RECEIVED FROM THE FIELD INDICATING THAT THIS LEAD PACE/SENSE PART WAS SURGICALLY ABANDONED AS THIS IS A STANDARD OPERATING PROCEDURE FOR THIS ELECTROPHYSIOLOGY AT UPGRADES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 573915 | ENDOTAK RELIANCE | IMPLANTABLE LEAD | LWS | BOSTON SCIENTIFIC CORPORATION | 0157 | 303727 | 00802526531125 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 79 YR | Female | Required Intervention| H |